Clinical Trials

The experimental vaccine uses the same groundbreaking mRNA technology that both Moderna and Pfizer utilized to create their Covid-19 vaccines.

The first phase of the trial was 97 percent successful in “stimulating production of rare immune cells” that are resistant to HIV.

For the first time, genes that cause HIV have been edited out by scientists working on lab rats and mice, and researchers hope to someday do the same for humans.

WASHINGTON — The U.S. Food and Drug Administration on Monday approved Truvada, the first drug approved to reduce the risk of HIV infection in uninfected individuals who are at high risk of HIV infection, or who may engage in sexual activity with HIV-infected partners.